• Portfolio

Oxford BioTherapeutics

Oxford BioTherapeutics is an oncology drug discovery business. By exploiting its proprietary database of human cell-surface proteins, it creates and develops novel targeted oncology therapeutics, with a focus on Antibody Drug Conjugates and Immune Oncology treatments.

Image for Oxford biotherapeutics - an oncology drug discovery business

Awards

Latest Oxford Capital News

Oxford Capital shortlisted for Most Impactful Investment at ...

Oxford Capital's investment in Push Doctor has been shortlisted for Most Impactful Investment at the...

Read more

Oxford Capital joins $10m Series A funding round in 'connect...

Curve - the UK fintech startup that combines your cards i...

Read more

Push Doctor raises $26.1M to help people live longer

Europe’s largest digital health provider, Push Doctor, today announced that it has raised $26.1M i...

Read more
More News